BUSINESS● LOWAug 11 · Aug 11, 2026, 11:33 AM
Bicara Therapeutics GAAP EPS of -$0.82 beats by $0.02
Seeking Alpha Tech
Bicara Therapeutics reported its GAAP EPS, which came in at -$0.82, exceeding expectations by $0.02. This indicates the company's financial performance relative to analyst predictions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS30m agoBlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billionCNBCBUSINESS35m agoSpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stageSeeking Alpha Tech